OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Lawrence Wennogle

1 Projects | 1 Researchers | $219,667 Invested

2012

Intra-Cellular Therapies, Inc.

Lawrence Wennogle, PhD

Validation of a Novel Target Mechanism to Counter Progresion of Alzheimer's Disease

  • Funding Amount: $219,667
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Status: Closed